Consonance Capital Management LP Sarepta Therapeutics, Inc. Transaction History

Consonance Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $27 Million - $37.9 Million	-409,301 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$69.38 - $86.75 $28.4 Million - $35.5 Million	409,301 New	409,301 $31.8 Million
Q3 2020 Nov 16, 2020	SELL	$127.12 - $172.34 $54.1 Million - $73.4 Million	-425,716 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $37 Million - $68.2 Million	-397,449 Reduced 48.28%	425,716 $68.3 Million
Q1 2020 May 15, 2020	BUY	$82.38 - $131.64 $38.5 Million - $61.5 Million	467,020 Added 131.13%	823,165 $80.5 Million
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $26.3 Million - $46.7 Million	344,145 Added 2867.88%	356,145 $46 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $873,720 - $1.88 Million	12,000 New	12,000 $904,000

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.